This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through July 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
moving-average-crossover: Archive
Allegro MicroSystems (ALGM) Moves 9.3% Higher: Will This Strength Last?
by Zacks Equity Research
Allegro MicroSystems (ALGM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
ALGMNegative Net Change FORMNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Insight Enterprises (NSIT) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
NSITPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Robinhood Markets (HOOD) Moves 8.8% Higher: Will This Strength Last?
by Zacks Equity Research
Robinhood Markets (HOOD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
HOODNegative Net Change MKTXPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
PTC Therapeutics (PTCT) Moves 7.2% Higher: Will This Strength Last?
by Zacks Equity Research
PTC Therapeutics (PTCT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
PTCTNegative Net Change BNTXPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
uniQure (QURE) Soars 78.4%: Is Further Upside Left in the Stock?
by Zacks Equity Research
uniQure (QURE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
QUREPositive Net Change ARVNPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
ClearPoint Neuro (CLPT) Surges 26.0%: Is This an Indication of Further Gains?
by Zacks Equity Research
ClearPoint Neuro (CLPT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
CLPTNegative Net Change PENPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Gildan (GIL) Moves 5.5% Higher: Will This Strength Last?
by Zacks Equity Research
Gildan (GIL) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
GILNegative Net Change RLNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Murata Manufacturing (MRAAY) Moves 9.6% Higher: Will This Strength Last?
by Zacks Equity Research
Murata Manufacturing (MRAAY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
MRAAYNegative Net Change AOSNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
OppFi (OPFI) Soars 6.3%: Is Further Upside Left in the Stock?
by Zacks Equity Research
OppFi (OPFI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
OPFINegative Net Change FOURPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Moderna (MRNA) Surges 6.3%: Is This an Indication of Further Gains?
by Zacks Equity Research
Moderna (MRNA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
MRNANegative Net Change CRSPPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today